Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II studyMengqing Xie, Chunxia Su, Li Liu et al.|Signal Transduction and Targeted Therapy|2025Cited by 6
Exploratory Biomarker Analysis of PD-1/CTLA-4 Bispecific Antibody Therapy Response in PD-L1-Negative Advanced Non-Small Cell Lung Cancer: Genomic and Transcriptomic Profiling from the Phase II LungCadX StudyWang Li, Chunxia Su, Zhixuan Ren et al.|SSRN Electronic Journal|2025Cited by 0